Reuters logo
BRIEF-Cadila Healthcare's Zydus gets final FDA nod for anti-hypertensive tablets
April 25, 2017 / 8:10 AM / 7 months ago

BRIEF-Cadila Healthcare's Zydus gets final FDA nod for anti-hypertensive tablets

April 25 (Reuters) - Cadila Healthcare Ltd

* Says Zydus receives final approval from USFDA for olmesartan medoxomil tablets

* Says drug is an anti-hypertensive to be produced at group manufacturing facility in Ahmedabad Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below